Latest filing published 17 Jun 2011 for Biostar Pharmaceuticals, Inc., €30k.
Insider track record
No signal scores available.
Closed purchases
Based on 19 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -49.5%Entry 22.89 · Close at T+365 11.55
- -44.2%Entry 22.47 · Close at T+365 12.53
- -70.5%Entry 25.62 · Close at T+365 7.56
- -70.0%Entry 25.20 · Close at T+365 7.56
- -72.2%Entry 26.46 · Close at T+365 7.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ronghua Wang: trading record in brief
This profile gathers the share dealings of Ronghua Wang in Biostar Pharmaceuticals, Inc. The record holds 19 filings, for trades running from 1 June 2011 to 16 June 2011.
Every open-market trade on record is a purchase: 19 purchases worth €170k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €7,320 and half below. After 19 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -21.3%. These figures describe past trades and do not predict future prices.
The newest entry dates from 17 June 2011: an open-market purchase of €30k, in Biostar Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ronghua Wang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,100 shares@ US$1.23Common StockSEC:0001185185-11-000888:0Canonical exit: 12 Sept 2011 (T+90)
- 14,350 shares@ US$1.19Common StockSEC:0001185185-11-000888:1Canonical exit: 13 Sept 2011 (T+90)
- 13,800 shares@ US$1.10Common StockSEC:0001185185-11-000888:2Canonical exit: 14 Sept 2011 (T+90)
- 19,700 shares@ US$1.21Common StockSEC:0001185185-11-000881:0Canonical exit: 8 Sept 2011 (T+90)
- 22,050 shares@ US$1.24Common StockSEC:0001185185-11-000881:1Canonical exit: 11 Sept 2011 (T+90)
- 34,600 shares@ US$1.26Common StockSEC:0001185185-11-000869:0Canonical exit: 6 Sept 2011 (T+90)
- 12,000 shares@ US$1.22Common StockSEC:0001185185-11-000869:1Canonical exit: 7 Sept 2011 (T+90)
- 10,300 shares@ US$1.24Common StockSEC:0001185185-11-000862:0Canonical exit: 4 Sept 2011 (T+90)
- 8,600 shares@ US$1.25Common StockSEC:0001185185-11-000862:1Canonical exit: 5 Sept 2011 (T+90)
- 6,900 shares@ US$1.27Common StockSEC:0001185185-11-000845:0Canonical exit: 1 Sept 2011 (T+90)
- 12,200 shares@ US$1.29Common StockSEC:0001185185-11-000838:0Canonical exit: 31 Aug 2011 (T+90)
- 1.09 shares@ US$1.30Common StockSEC:0001185185-11-000832:0Canonical exit: 30 Aug 2011 (T+90)
- 1,811 shares@ US$1.31Common StockSEC:0001185185-11-000832:1Canonical exit: 30 Aug 2011 (T+90)
- 2,500 shares@ US$1.32Common StockSEC:0001185185-11-000832:2Canonical exit: 30 Aug 2011 (T+90)
- 1,700 shares@ US$1.33Common StockSEC:0001185185-11-000832:3Canonical exit: 30 Aug 2011 (T+90)
- 1,700 shares@ US$1.35Common StockSEC:0001185185-11-000832:4Canonical exit: 30 Aug 2011 (T+90)
- 1,300 shares@ US$1.36Common StockSEC:0001185185-11-000832:5Canonical exit: 30 Aug 2011 (T+90)
- 200 shares@ US$1.37Common StockSEC:0001185185-11-000832:6Canonical exit: 30 Aug 2011 (T+90)
- 100 shares@ US$1.38Common StockSEC:0001185185-11-000832:7Canonical exit: 30 Aug 2011 (T+90)
19 of 19 declarations